ASSOCIATION BETWEEN TUMOR-STROMA RATIO AND LYMPH NODE METASTASIS IN PATIENTS WITH GASTRIC ADENOCARCINOMA

Văn Đề Nguyễn1, , Thu Hương Nguyễn2, Văn Cương Nguyễn2
1 Bệnh viện Trung ương Quân đội 108
2 Bệnh viện K cơ sở Tân Triều

Main Article Content

Abstract

Objective: To analyze the association between the tumor-stroma ratio (TSR) on histopathological slides and lymph node metastasis in patients with gastric adenocarcinoma undergoing radical surgery.


Subjects and methods: A retrospective cross-sectional study of 72 patients with gastric adenocarcinoma who underwent radical gastrectomy with lymph node dissection at K Hospital, Tan Trieu campus (1/2025–6/2026). TSR was assessed on H&E slides of the invasive area and classified into stroma-poor (stroma ≤50%) and stroma-rich (>50%) groups. The association with lymph node metastasis was analyzed by multivariable logistic regression adjusted for pT and lymphovascular invasion.


Results: Mean age was 59.9 ± 10.3 years; 68.1% were male. Lymph node metastasis was present in 56.9% and stroma-rich TSR in 41.7%. The stroma-rich group had a higher rate of nodal metastasis (80.0% vs 40.5%; p=0.002) and a higher rate of pT3–pT4 (p=0.036). After adjustment, stroma-rich TSR was independently associated with lymph node metastasis (aOR 4.68; 95% CI: 1.32–16.64; p=0.017), together with pT3–pT4 (aOR 8.95).


Conclusion: Stroma-rich TSR was associated with lymph node metastasis in patients with gastric adenocarcinoma, and this association remained after adjustment for depth of invasion and lymphovascular invasion.

Article Details

References

1. Sung H, Ferlay J, Siegel RL, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3):209-249.
2. Smyth EC, Nilsson M, Grabsch HI, et al. (2020). Gastric cancer. Lancet, 396(10251):635-648.
3. Lauren P. (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand, 64:31-49.
4. Mesker WE, Junggeburt JMC, Szuhai K, et al. (2007). The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol, 29(5):387-398.
5. Wu J, Liang C, Chen M, et al. (2016). Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis. Oncotarget, 7(42):68954-68965.
6. Kemi N, Eskuri M, Herva A, et al. (2018). Tumour-stroma ratio and prognosis in gastric adenocarcinoma. Br J Cancer, 119(4):435-439.
7. Van Pelt GW, Sandberg TP, Morreau H, et al. (2018). The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology, 73(2):197-206.
8. Kalluri R. (2016). The biology and function of fibroblasts in cancer. Nat Rev Cancer, 16(9):582-598.
9. Hynes RO. (2009). The extracellular matrix: not just pretty fibrils. Science, 326(5957):1216-1219.